Genesee Valley Trust’s Novartis NVS Stock Holding History

Genesee Valley Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$286K	Buy	3,828 +11	+0.3%	+$837	0.12%	153
2017 Q4	$287K	Sell	3,817 -173	-4%	-$13.1K	0.12%	155
2017 Q3	$307K	Sell	3,990 -78	-2%	-$5.89K	0.13%	151
2017 Q2	$304K	Sell	4,068 -173	-4%	-$12.3K	0.13%	149
2017 Q1	$282	Buy	4,241 +413	+11%	+$27.5K	0.19%	159
2016 Q4	$249	Sell	3,828 -1,672	-30%	-$108K	0.18%	190
2016 Q3	$389K	Buy	5,500 +55	+1%	+$4.01K	0.24%	131
2016 Q2	$403K	Buy	5,445 +119	+2%	+$8.22K	0.26%	122
2016 Q1	$346K	Buy	5,326 +862	+19%	+$58.6K	0.23%	139
2015 Q4	$344K	Sell	4,464 -200	-4%	-$15.9K	0.23%	147
2015 Q3	$384K	Sell	4,664 -2,474	-35%	-$220K	0.26%	126
2015 Q2	$629K	Sell	7,138 -499	-7%	-$45.8K	0.41%	66
2015 Q1	$675K	Buy	7,637 +11	+0.1%	+$976	0.42%	60
2014 Q4	$633K	Sell	7,626 -1,660	-18%	-$138K	0.4%	69
2014 Q3	$783K	Buy	9,286 +167	+2%	+$13.5K	0.49%	46
2014 Q2	$740K	Sell	9,119 -4,184	-31%	-$329K	0.44%	51
2014 Q1	$1.01M	Buy	13,303 +557	+4%	+$40.6K	0.64%	35
2013 Q4	$918K	Sell	12,746 -82	-0.6%	-$5.7K	0.61%	35
2013 Q3	$882K	Sell	12,828 -995	-7%	-$65.8K	0.65%	29
2013 Q2	$876K	Buy	+13,823	New	+$899K	0.69%	27

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Genesee Valley Trust's NVS Position: Q1 2018 in Review

Genesee Valley Trust increased its Novartis (NVS) stake by 0.29% in Q1 2018, buying an estimated $837 and bringing the position to 3,828 shares worth $286K. The position accounts for 0.12% of the portfolio, ranked #153.

Genesee Valley Trust first reported a position in NVS in Q2 2013 and has held it in 20 quarters since. The position peaked at $1.01M in Q1 2014. 1,012 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

Genesee Valley Trust held 3,828 shares of Novartis worth $286K as of Q1 2018.
Genesee Valley Trust bought 11 Novartis shares in Q1 2018, an estimated $837.
Novartis made up 0.12% of Genesee Valley Trust's portfolio in Q1 2018, its #153 holding.
Genesee Valley Trust first reported a position in Novartis in Q2 2013 and has held it in 20 quarters since.
Genesee Valley Trust's Novartis position peaked at $1.01M in Q1 2014.
1,012 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on Genesee Valley Trust's 13F filing for Q1 2018, filed 3 Apr 2018.